Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

AIMS: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of 2.0–3.0 for stroke prevention in atrial fibrillation (AF). We analysed the time in this therapeutic range (TTR) of VKA-treated patients with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Haas, Sylvia, ten Cate, Hugo, Accetta, Gabriele, Angchaisuksiri, Pantep, Bassand, Jean-Pierre, Camm, A. John, Corbalan, Ramon, Darius, Harald, Fitzmaurice, David A., Goldhaber, Samuel Z., Goto, Shinya, Jacobson, Barry, Kayani, Gloria, Mantovani, Lorenzo G., Misselwitz, Frank, Pieper, Karen, Schellong, Sebastian M., Stepinska, Janina, Turpie, Alexander G. G., van Eickels, Martin, Kakkar, Ajay K.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085020/
https://ncbi.nlm.nih.gov/pubmed/27792741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0164076
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires